Document is current
Any future updates will be listed below
-
Authors
Mao, Xiangyun https://orcid.org/0009-0000-0233-5523
Zeng, Dian https://orcid.org/0000-0002-5592-9584
Wang, Xiaocong
Pearce, David A.
Baynam, Gareth https://orcid.org/0000-0003-4920-9553
Chavannes, Niels H.
Chung, Wendy K. https://orcid.org/0000-0003-3438-5685
Wu, Honghan https://orcid.org/0000-0002-0213-5668
Tham, Yih-Chung https://orcid.org/0000-0002-6752-797X
Zhang, Shuyang https://orcid.org/0000-0002-1532-0029
Li, Guanqiao https://orcid.org/0000-0002-3626-7220
Wong, Tien Yin https://orcid.org/0000-0002-8448-1264
-
Funding
Funding for this research was provided by:
National Natural Science Foundation of China (72374119)
Beijing Nova Program
- License Information
-
More Information
Article History
Received: 11 April 2025
Accepted: 26 August 2025
First Online: 31 October 2025
Competing interests
: T.W. is the deputy group chief executive officer (research and education) of Singapore Health Services, a consultant & advisory board for Allergan, Bayer, Boehringer-Ingelheim, Genentech, Merck, Novartis, Oxurion (formerly ThromboGenics), Roche, and co-founder of plano and EyRiS. The remaining authors declare no competing interests.
